Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.760
+0.050 (1.85%)
Apr 29, 2026, 4:08 PM HKT
14.52% (1Y)
| Market Cap | 7.12B |
| Revenue (ttm) | 763.16M |
| Net Income (ttm) | -175.20M |
| Shares Out | 1.04B |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (1.16%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 391,000 |
| Average Volume | 1,633,500 |
| Open | 2.770 |
| Previous Close | 2.710 |
| Day's Range | 2.710 - 2.770 |
| 52-Week Range | 2.390 - 5.290 |
| Beta | 0.19 |
| RSI | 39.27 |
| Earnings Date | Apr 29, 2026 |